T
0.012
0.00 (-14.29%)
| Previous Close | 0.014 |
| Volume | 115,833 |
| Price / Sales | 57.83 |
| Price / Book | 0.870 |
| 52 Weeks Range |
| Profit Margin | -22.05% |
| Operating Margin (TTM) | -5.80% |
| Diluted EPS (TTM) | 0.000 |
| Quarterly Revenue Growth (YOY) | 5,176.80% |
| Total Debt/Equity (MRQ) | 1.71% |
| Current Ratio (MRQ) | 1.11 |
| Operating Cash Flow (TTM) | -1.48 M |
| Levered Free Cash Flow (TTM) | -2.18 M |
| Return on Assets (TTM) | -2.41% |
| Return on Equity (TTM) | -4.44% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (AU) | Mixed | Mixed |
| Health Information Services (Global) | Mixed | Bearish | |
| Stock | TRIVARX FPO [TRI] | - | - |
AIStockmoo Score
1.1
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | -0.5 |
| Average | 1.07 |
|
TrivarX Ltd is a health technology company developing AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions. Trivarx’s clinical research has enabled the development of cutting-edge proprietary algorithms for spectral analyses of sleep architecture and heart rate variability. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Value |
| % Held by Insiders | 26.31% |
| % Held by Institutions | 6.86% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |